Journal of the American Heart Association
Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer.
Giselle Alexandra Suero-Abreu, Zsofia D Drobni, Carlos A Gongora, Jana Taron, Julia Karady, Hannah K Gilman, Bela Merkely, Hajnalka Vago, Zoltan V Varga, Ryan J Sullivan, Kerry L Reynolds, Daniel Zlotoff, Borek Foldyna, Markella V Zanni, Tomas G Neilan
Published: 202510.1161/JAHA.125.041925
Abstract
BACKGROUND: Immune checkpoint inhibitors (ICIs) are associated with a 3-fold risk of atherosclerotic cardiovascular disease (ASCVD). However, the biology of atherosclerosis is different among women and men, and ASCVD risk factors among women treated…
Preview only. Read the full abstract at the source